DCTH

Delcath Systems Stock Price

9.80
-0.07 (-0.71%)
Upgrade to Real-Time
Regular Market
9.80

Low
8.00

52 Week Range

High
25.18

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type
Delcath Systems Inc DCTH NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.07 -0.71% 9.80 13:20:33
Open Price Low Price High Price Close Price Prev Close
9.94 9.80 10.14 9.87
Bid Price Ask Price Spread News
9.81 9.93 0.12 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
180 20,022 $ 9.95 $ 199,152 57,391 8.00 - 25.18
Last Trade Time Type Quantity Stock Price Currency
13:17:33 300 $ 9.80 USD

Delcath Systems Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 63.43M 6.47M 6.39M $ 1.65M $ - -111.73 -2.20
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 664.50k 49.60%

more financials information »

Delcath Systems News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical DCTH Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week11.6112.059.6410.4844,874-1.81-15.59%
1 Month10.6512.629.6411.1050,980-0.85-7.98%
3 Months15.9821.009.4212.47264,102-6.18-38.67%
6 Months18.6925.189.4214.56182,675-8.89-47.57%
1 Year8.3325.188.0014.23123,5261.4717.65%
3 Years3.7725.186.0613.75117,4316.03159.95%
5 Years4.76825.180.0150.19455614,636,4865.03105.54%

Delcath Systems Description

Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product candidate, Melphalan Hydrochloride for Injection for use with the Delcath Hepatic Delivery System, or Melphalan/HDS, is designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.


Your Recent History
NASDAQ
DCTH
Delcath Sy..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.